Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Barbara K. Klein
Receptor Binding Kinetics of Human IL-3 Variants With Altered Proliferative Activity
Biochemical and Biophysical Research Communications
Biochemistry
Cell Biology
Molecular Biology
Biophysics
Related publications
Expression of Interleukin (IL)-11 and IL-11 Receptor in Human Colorectal Adenocarcinoma: IL-11 Up-Regulation of the Invasive and Proliferative Activity of Human Colorectal Carcinoma Cells
International Journal of Oncology
Cancer Research
Oncology
Altered Expression of Ano1 Variants in Human Diabetic Gastroparesis
Journal of Biological Chemistry
Biochemistry
Cell Biology
Molecular Biology
Human Platelet 12-Lipoxygenase: Naturally Occurring Q261/R261 Variants and N544L Mutant Show Altered Activity but Unaffected Substrate Binding and Membrane Association Behavior
International Journal of Molecular Medicine
Medicine
Genetics
Nucleotide Sequence of Mouse IL-2 Receptor cDNA and Its Comparison With the Human IL-2 Receptor Sequence
Nucleic Acids Research
Genetics
Altered Ca2+ Kinetics Associated With Α-Actinin-3 Deficiency May Explain Positive Selection for ACTN3 Null Allele in Human Evolution
PLoS Genetics
Evolution
Ecology
Genetics
Molecular Biology
Cancer Research
Systematics
Behavior
Interleukin (IL)-2 and IL-3 Induce Distinct but Overlapping Responses in Murine IL-3-dependent 32D Cells Transduced With Human IL-2 Receptor Beta Chain: Involvement of Tyrosine Kinase(s) Other Than P56lck.
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
A New Isoform of Interleukin-3 Receptor Α With Novel Differentiation Activity and High Affinity Binding Mode
Journal of Biological Chemistry
Biochemistry
Cell Biology
Molecular Biology
Altered Cerebral Benzodiazepine Receptor Binding in Post-Traumatic Stress Disorder
Translational Psychiatry
Psychiatry
Molecular Neuroscience
Biological Psychiatry
Mental Health
Cellular
Altered Androgen Receptor Activity Drives CHD1-Null Prostate Cancer
Cancer Discovery
Oncology